Generation and multiomic profiling of a<i>TP53/CDKN2A</i>double-knockout gastroesophageal junction organoid modelHua Zhao, Stephen J. Meltzer, Vikesh K. Singh et al.|Science Translational Medicine|2022Cited by 47
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancersTushar D. Nichakawade, Suman Paul, Stephanie Glavaris et al.|Nature|2024Cited by 43
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densitiesBrian J. Mog, Shibin Zhou, Stephanie Glavaris et al.|Science Translational Medicine|2024Cited by 23
Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscapeAshley L. Cook, Nicolas Wyhs|eLife|2024Cited by 8
NXPE1 alters the sialoglycome by acetylating sialic acids in the human colonBum Seok Lee, Nicolas Wyhs|Nature Communications|2025Cited by 2